Findings from three research studies have shown that around three quarters of
cancer patients who suffer from major depression do not receive treatment for
their depression and that a newly developed medical program has proven more
effective than standard care at reducing depression in these patients.
As reported in The Lancet Psychiatry, a data analysis of more than
21,000 patients across clinics in Scotland, UK, found that the frequency of
major depression among cancer patients ranged from 6% in those with
genitourinary cancer to 13% among those with lung cancer. However, almost three quarters
of patients with major depression were not receiving any treatment to address
the problem.
The second paper published in The Lancet, reports on findings form the
SMaRT Oncology-2 randomised trial
which examined the effects of a new medical programme called “Depression Care
for People with Cancer” (DCPC).
A further study published in The Lancet Oncology describes a version of
the DCPC that was adjusted for lung cancer patients with major depression who
had a poor rather than good cancer prognosis.
CIAP users can access the full text of The Lancet and Lancet Oncology. Contact your library for access to Lancet Psychiatry.
No comments:
Post a Comment